2024 Virtual Grand Rounds
2024 Virtual Grand Rounds Session 5: April 3, 2024 -E-Journal Club Edition: What's New in SKIN, The Journal of Cutaneous Medicine
About
Fall Clinical Virtual Grand Rounds consist of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:
Wednesday, April 3, 2024
8 PM ET / 5 PM PT
E-Journal Club Edition: What's New in SKIN, The Journal of Cutaneous Medicine
Join authors from 2 recently published articles that will impact the way you practice. Preview the articles and ask your questions to the authors, who will review how this information can elevate your patient care tomorrow!
Article 1: New Onset Generalized Pustular Psoriasis Rapidly Improved with IL-36 Blockade
https://www.jofskin.org/index.php/skin/article/view/1790
Author: Boni Elewski, MD
Article 2: Weekly Isotretinoin Therapy (WIT) Study: A Potential Alternative for the Treatment of Moderate Acne Vulgaris
https://jofskin.org/index.php/skin/article/view/1485
Author: Lara Wine Lee, MD, PhD
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
April 4, 2024
April 4, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Recognize the clinical presentation of GPP and how to diagnose it
Be familiar with the current GPP treatment options such as the IL-36 pathway
Discuss the implications of alternatives to oral antibiotics and hormonal therapies for moderate acne vulgaris
Assess whether patients with moderate Acne Vulgaris can benefit from weekly isotretinoin therapy
Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Boni Elewski, MD
James Elder Professor and Chair of Dermatology
University of Alabama at Birmingham
Birmingham, AL
Linda Stein Gold, MD
Director Clinical Research
Henry Ford Health System
Detroit, MI
Lara Wine Lee, MD, PhD
Medical University of South Carolina
Associate Professor
Department of Pediatrics and Dermatology
Charleston, SC
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: Ortho Dermatology
Consultant: Ortho Dermatology
Grant/Research Support: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie
Consultant: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie
Speakers’ Bureau or Honoraria: Leo, AbbVie, Almirall, Galderma, Pfizer, Sanofi, Regeneron
Advisory Board: Eli Lilly, Regeneron, Pfizer, Castle Creek
Investigator: Eli Lilly, Sanofi, Regeneron, Pfizer, Trevi Therapeutics, Abbvie, Mayne Pharmaceuticals, Incyte, Castle Creek, Amyrt, Arcutis, Celgene, Target Pharma, Amgen, Novartis, UCB, Galderma, Kiniksa, Avita, Janssen, MoonLake Pharmaceuticals, Timber Pharmaceuticals
Consultant/Speaker's Bureau: Abbvie, Pyramid Bioscience, Amyrt, Krystal Biotech, Novartis
The Institute discloses that all relevant conflicts have been satisfactorily mitigated.